Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Reference
Endpoint:
basic toxicokinetics in vivo
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
4 (not assignable)
Rationale for reliability incl. deficiencies:
secondary literature
Justification for type of information:
Data is from European Food Safety Authority
Objective of study:
absorption
distribution
excretion
metabolism
Qualifier:
according to guideline
Guideline:
other: as below
Principles of method if other than guideline:
In vivo Absorption, Distribution, Excretionand Metabolism study of 44-( Metam-sodium in mice and rat
GLP compliance:
not specified
Specific details on test material used for the study:
- Name of test material (as cited in study report): Metam-sodium
- Molecular formula (if other than submission substance): C2H4NNaS2
- Molecular weight (if other than submission substance): 129.1826 g/mole
- Substance type: Organic
Radiolabelling:
not specified
Species:
other: Mice and rat
Strain:
not specified
Sex:
not specified
Route of administration:
not specified
Vehicle:
not specified
Details on exposure:
not specified
Duration and frequency of treatment / exposure:
not specified
Remarks:
not specified
No. of animals per sex per dose / concentration:
not specified
Control animals:
not specified
Positive control reference chemical:
not specified
Details on study design:
not specified
Details on dosing and sampling:
not specified
Statistics:
not specified
Preliminary studies:
not specified
Type:
absorption
Results:
Oral absorption of metam is rapid and almost complete (85%) based on urinary and expired air excretion (50 and 35%, respectively).
Type:
distribution
Results:
Metam is uniformly distributed with slight accumulation in the thyroid in mice and rats
Type:
metabolism
Results:
The metabolism of metam is extensive and rapid, suggesting a decomposition of metam into MITC, CO2, and COS. MITC is further conjugated to glutathione and excreted in urine while CO2 and COS are excreted via expired air.
Type:
excretion
Results:
Excretion is almost complete within 24-48 h after administration, with minor portions excreted up to 168 h after dosing.
Details on absorption:
Oral absorption of metam is rapid and almost complete (85%) based on urinary and expired air excretion (50 and 35%, respectively).
Details on distribution in tissues:
Metam is uniformly distributed with slight accumulation in the thyroid in mice and rats
Details on excretion:
Excretion is almost complete within 24-48 h after administration, with minor portions excreted up to 168 h after dosing.
Metabolites identified:
yes
Remarks:
MITC, CO2, and COS. MITC, CS2
Details on metabolites:
The metabolism of metam is extensive and rapid, suggesting a decomposition of metam into MITC, CO2, and COS. MITC is further conjugated to glutathione and excreted in urine while CO2 and COS are excreted via expired air. The other significant pathway for metam is the release of CS2, which could be related to the acidic conditions existent in the stomach of the rat (pH=3.8-5) following oral ingestion.
Conclusions:
Low bio-accumulation potential based on study results
Executive summary:

Available data pertaining to the in-vivo Absorption,Distribution, Metabolism and Excretion of the chemical 4-(Metam-sodium suggests absorbed Orally rapid and almost complete (85%) based on urinary and expired air excretion (50 and 35%, respectively) and uniformly distributed with slight accumulation in the thyroid in mice and rats. The metabolism of metam is extensive and rapid, suggesting a decomposition of metam into MITC, CO2, and COS. MITC is further conjugated to glutathione and excreted in urine while CO2 and COS are excreted via expired air. The other significant pathway for metam is the release of CS2, which could be related to the acidic conditions existent in the stomach of the rat (pH=3.8-5) following oral ingestion. Excretion is almost complete within 24-48 h after administration, with minor portions excreted up to 168 h after dosing.Thus, there is low evidence of4-(Metam-sodiumto accumulate in tissues and cause a concern for consumer safety. Also, th use as a pesticide, plant fumigant to control weeds, nematodes, fungi, bacteria and insects (United states environment protaction agecny, 1994). Hence it is concluded that Metam-sodiumis likely to exhibit low bio-accumulation potential based on study results and use.    

Description of key information

There is low evidence of 4-(Metam-sodiumto accumulate in tissues and cause a concern for consumer safety. Also, it use as a pesticide, plant fumigant to control weeds, nematodes, fungi, bacteria and insects (United states environment protaction agecny, 1994). Hence it is concluded that Metam-sodiumis likely to exhibit low bio-accumulation potential based on study results and use.    

Key value for chemical safety assessment

Bioaccumulation potential:
low bioaccumulation potential

Additional information

Available data pertaining to the in-vivo Absorption,Distribution, Metabolism and Excretion of the chemical 4-(Metam-sodium suggests absorbed Orally rapid and almost complete (85%) based on urinary and expired air excretion (50 and 35%, respectively) and uniformly distributed with slight accumulation in the thyroid in mice and rats. The metabolism of metam is extensive and rapid, suggesting a decomposition of metam into MITC, CO2, and COS. MITC is further conjugated to glutathione and excreted in urine while CO2 and COS are excreted via expired air. The other significant pathway for metam is the release of CS2, which could be related to the acidic conditions existent in the stomach of the rat (pH=3.8-5) following oral ingestion. Excretion is almost complete within 24-48 h after administration, with minor portions excreted up to 168 h after dosing.Thus, there is low evidence of4-(Metam-sodiumto accumulate in tissues and cause a concern for consumer safety. Also, th use as a pesticide, plant fumigant to control weeds, nematodes, fungi, bacteria and insects (United states environment protaction agecny, 1994). Hence it is concluded that Metam-sodiumis likely to exhibit low bio-accumulation potential based on study results and use.